Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 1 TO FORM S-1 - Amneal Pharmaceuticals, Inc. | d414240ds1a.htm |
| EX-23.2 - EX-23.2 - Amneal Pharmaceuticals, Inc. | d414240dex232.htm |
Exhibit 23.3
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 7, 2018, in Amendment No. 1 to the Registration Statement (Form S-1 333-224702) and related Prospectus of Amneal Pharmaceuticals, Inc. for the registration of 224,996,163 shares of its Class A common stock.
/s/ Ernst & Young LLP
Iselin, New Jersey
May 9, 2018